ClinicalTrials.Veeva

Menu

Therapeutic Drug Monitoring of Tacrolimus Biliary Concentrations for Liver-transplanted Patients (STABILE)

R

Rennes University Hospital

Status

Completed

Conditions

Biliary Concentration of Tacrolimus

Treatments

Drug: Tacrolimus

Study type

Observational

Funder types

Other

Identifiers

NCT02820259
35RC16_9755

Details and patient eligibility

About

The purpose of this study is to demonstrate that the biliary concentration of TCR is a good marker of its immunosuppressive activity.

Enrollment

42 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients (> 18 years) of both sexes,
  • Candidates for liver transplantation or retransplantation, whatever the etiology and severity of the underlying disease,
  • Not having expressed their opposition to participation in the study

Exclusion criteria

  • Bilio-enteric anastomosis,
  • Associated transplantation of another organ
  • Contraindications to TCR administration
  • Delayed introduction of TCR (beyond the 5th postoperative day) whatever the cause.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems